NEW YORK (GenomeWeb News) – DNAnexus today announced deals with the Geisinger Health System and the University of California, San Francisco to develop clinically relevant workflows.
The workflows will provide new information for the use of DNA sequencing in clinical applications, the Mountain View, Calif.-based data management and analysis firm said.
As part of the deals, laboratories at Geisinger and UCSF will leverage DNAnexus' cloud-based software platform to upload, store, and analyze sequencing data. Additionally, in conjunction with the Geisinger Clinical Program for Whole Genome Sequencing, Geisinger will be able to access DNAnexus' genomic data management capabilities, such as visualization, analysis, and storage.
Geisinger will provide "strategic counsel" for the use of next-generation sequencing data for clinical applications and will extend DNAnexus' capabilities to support use of the data.
Financial terms of the agreements were not disclosed.
DNAnexus was founded in 2009 and provides solutions to sequencing centers and researchers working with next-gen sequencing data. In the fall, it announced it had raised $15 million and would collaborate with Google to support hosting of the public Sequence Read Archive database.
"By partnering with highly respected healthcare and research institutions like Geisinger and UCSF, we will be able to learn from clinical experts and build an even more innovative solution that will enable research, medical, and biotech communities to unlock the full potential of DNA data," Andreas Sundquist, co-founder and CEO of DNAnexus, said in a statement.